The Full Wiki

Souba: Misc


Final Fantasy

Up to date as of February 01, 2010

From Final Fantasy Wiki

Kadaj wielding Souba

The Souba (双刃) is a kind of weapon which appeared in Final Fantasy VII: Advent Children, and is the main weapon of Kadaj, leader of the Remnants of Sephiroth who appear in the movie. The Souba is a katana with two reinforced parallel blades, set a small distance apart from each other, the intent of the design to trap an opponent's sword between them and disarm them. Despite being much smaller than the Fusion Swords, Kadaj is able to battle Cloud using the sword with no apparent handicap, using the sword's dual blades to also give it a wider striking range and more easily deflect Cloud's attacks than a more narrow sword would be able to.

The blade is lost in the ruins of Midgar during his final battle with Cloud, but after Kadaj reforms into Sephiroth and is subsequently defeated, it regenerates with him. Following his death in Aerith's Great Gospel Limit Break, both Kadaj and the sword vanish into the Lifestream.

Some of the Souba's replicas can be split into two katanas, but this feature has not been officially confirmed.

Non-Final Fantasy appearances

A similar weapon is seen in the manga Rurouni Kenshin by Watsuki Nobuhiro. In chapter 78, the character Chou is seen using what he called a "renbatou", which he produced by disassembling and reassembling two katanas together into one. Chou remarked that one advantage of using such a weapon is due to its design. Because the two blades are so close to one another, the cuts that the renbatou inflict do not have to be aimed at vital spots, as the cuts cannot be stitched up. The victim would supposedly die of untreatable wounds.


  • Surprisingly, the two blades of the Souba could match the actual length of Sephiroth's Masamune if lined up. In itself, this is also could be a reference of Kadaj being a remnant of Sephiroth.

This article uses material from the "Souba" article on the Final Fantasy wiki at Wikia and is licensed under the Creative Commons Attribution-Share Alike License.


Got something to say? Make a comment.
Your name
Your email address